• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FERRING PHARMACEUTICALS, INC./ BIO-TECHNOLOGY GENERAL (ISREAL) LTD. EUFLEXXA 1% SOLUTION FOR INJ. 10MG/1ML; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FERRING PHARMACEUTICALS, INC./ BIO-TECHNOLOGY GENERAL (ISREAL) LTD. EUFLEXXA 1% SOLUTION FOR INJ. 10MG/1ML; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Anemia (1706)
Event Date 12/20/2019
Event Type  Injury  
Event Description
The patient was in the hospital due to being anemic.Stated they added an antacid for 30 days but didn¿t know the name of it.No missed dose.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA 1% SOLUTION FOR INJ. 10MG/1ML
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
FERRING PHARMACEUTICALS, INC./ BIO-TECHNOLOGY GENERAL (ISREAL) LTD.
MDR Report Key9538823
MDR Text Key173507708
Report NumberMW5091958
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier55566410001
UDI-Public55566410001
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Type of Report Initial
Report Date 12/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/31/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Age55 YR
-
-